{"id":12038,"date":"2021-02-08T15:58:21","date_gmt":"2021-02-08T15:58:21","guid":{"rendered":"https:\/\/clone.arsacs.com\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/"},"modified":"2026-03-16T18:12:47","modified_gmt":"2026-03-16T22:12:47","slug":"la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares","status":"publish","type":"post","link":"https:\/\/arsacs.com\/fr\/la-fondation-partenaire-dun-projet-finance-dans-le-cadre-du-programme-commun-europeen-des-maladies-rares\/","title":{"rendered":"La Fondation, partenaire d\u2019un projet financ\u00e9 dans le cadre du programme commun europ\u00e9en des maladies rares"},"content":{"rendered":"La Fondation est heureuse d\u2019annoncer qu\u2019elle repr\u00e9sentera les patients de l\u2019ARSACS dans le cadre du projet de recherche <em>\u201c Conception d\u2019une bo\u00eete \u00e0 outils de traitements paradigmatiques pour une approche de m\u00e9decine mol\u00e9culaire cibl\u00e9e des ataxies autosomiques r\u00e9cessives \u201d <\/em>. Le projet a re\u00e7u des fonds du programme de recherche et d\u2019innovation Horizon 2020 de l\u2019Union europ\u00e9enne sous EJPR (European Joint Programme Rare Diseases)  COFUND-EJP N\u00b0 825575. L\u2019objectif sp\u00e9cifique est la recherche pr\u00e9clinique pour d\u00e9velopper des th\u00e9rapies efficaces pour les maladies rares. On vise \u00e0 concevoir et \u00e0 tester de nouvelles strat\u00e9gies de traitement compl\u00e9mentaires, y compris des mol\u00e9cules r\u00e9utilis\u00e9es et nouvellement identifi\u00e9es, ainsi que des th\u00e9rapies g\u00e9niques dans deux multisyst\u00e8mes ARCAS exemplaires: l\u2019ataxie spastique r\u00e9cessive autosomique de Charlevoix-Saguenay (ARSACS) et COQ8A-ataxie (ARCA2). Il s\u2019agit d\u2019un projet de 3 ans.","protected":false},"excerpt":{"rendered":"<p>La Fondation est heureuse d\u2019annoncer qu\u2019elle repr\u00e9sentera les patients de l\u2019ARSACS dans le cadre du projet de recherche \u201cDesigning a toolbox of paradigmatic treatments for a targeted molecular medicine approach to autosomal-recessive ataxias\u201d . Le projet a re\u00e7u des fonds du programme de recherche et d\u2019innovation Horizon 2020 de l\u2019Union europ\u00e9enne sous EJPR (European Joint [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":11559,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[28],"tags":[],"class_list":["post-12038","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dernieres-nouvelles"],"_links":{"self":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/12038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/comments?post=12038"}],"version-history":[{"count":1,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/12038\/revisions"}],"predecessor-version":[{"id":24677,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/12038\/revisions\/24677"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media\/11559"}],"wp:attachment":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media?parent=12038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/categories?post=12038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/tags?post=12038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}